Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19

标题
Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
作者
关键词
SARS-CoV-2, COVID 19, Baricitinib, Novel Corona Virus
出版物
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 55, Issue 5, Pages 105967
出版商
Elsevier BV
发表日期
2020-04-04
DOI
10.1016/j.ijantimicag.2020.105967

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search